Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences
Lexicon Pharmaceuticals (Nasdaq: LXRX) will present at three investor conferences in New York: Citi 2026 Biopharma Back to School Conference on September 9, 2026; 2026 Cantor Global Healthcare Conference on September 10, 2026; and H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lexicon Pharmaceuticals (Nasdaq: LXRX) will present at three investor conferences in New York: Citi 2026 Biopharma Back to School Conference on September 9, 2026; 2026 Cantor Global Healthcare Conference on September 10, 2026; and H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026.
According to Lexicon Pharmaceuticals, live webcasts and replays of the presentations will be available via the Events page on its investor relations website.
Details
News Market Reaction – LXRX
On Sep 2, the first trading day after this news, LXRX closed 2.51% above the previous close.
Data tracked by StockTitan Argus for the Sep 2 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
THE WOODLANDS, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that company management will present at three upcoming investor conferences taking place in New York, NY:
Citi 2026 Biopharma Back to School Conference
September 9, 2026, 11:20–11:55 AM (Eastern Time)
2026 Cantor Global Healthcare Conference
September 10, 2026, 3:20–3:50 PM (Eastern Time)
H.C. Wainwright 28th Annual Global Investment Conference
September 14, 2026, 9:00–9:30 AM (Eastern Time)
The live events and replays of the presentations can be accessed via the Events page on the company’s website at https://investors.lexpharma.com/.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.
For Media Inquiries:
Dave Belian
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
For Investor Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.